Silvia Celis-De

Essen, NW 45147, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

KRAS-ERK signaling drives metastasis in colorectal cancer via phosphorylation-dependent activation of the ZBTB20-TGFBR2 axis.

KRAS-ERK signaling drives metastasis in colorectal cancer via phosphorylation-dependent activation of the ZBTB20-TGFBR2 axis.

Journal: Journal of experimental & clinical cancer research : CR
Published: September 27, 2025

Autophagy suppression via SRC induction represents a therapeutic vulnerability for BAP1-mutant cancers.

Autophagy suppression via SRC induction represents a therapeutic vulnerability for BAP1-mutant cancers.

Journal: Autophagy
Published: August 04, 2025

Kit-mediated autophagy suppression driven by a viral oncoprotein emerges as a crucial survival mechanism in Merkel cell carcinoma.

Kit-mediated autophagy suppression driven by a viral oncoprotein emerges as a crucial survival mechanism in Merkel cell carcinoma.

Journal: Autophagy
Published: March 20, 2025

HHLA2 activates c-Met and identifies patients for targeted therapy in hepatocellular carcinoma.

HHLA2 activates c-Met and identifies patients for targeted therapy in hepatocellular carcinoma.

Journal: Journal of experimental & clinical cancer research : CR
Published: January 21, 2025

GRB2, a protein known for a long time with a new autophagy-regulating function.

GRB2, a protein known for a long time with a new autophagy-regulating function.

Journal: Autophagy reports
Published: March 06, 2024

GRB2 is a BECN1 interacting protein that regulates autophagy.

GRB2 is a BECN1 interacting protein that regulates autophagy.

Journal: Cell death & disease
Published: June 13, 2023

TROP2 expression and SN38 antitumor activity in malignant pleural mesothelioma cells provide a rationale for antibody-drug conjugate therapy.

TROP2 expression and SN38 antitumor activity in malignant pleural mesothelioma cells provide a rationale for antibody-drug conjugate therapy.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 12, 2022

Editorial: Molecular Mechanisms of Autophagy in Cancer.

Editorial: Molecular Mechanisms of Autophagy in Cancer.

Journal: Frontiers in cell and developmental biology
Published: April 12, 2022

Beth Levine's Legacy: From the Discovery of BECN1 to Therapies. A Mentees' Perspective.

Beth Levine's Legacy: From the Discovery of BECN1 to Therapies. A Mentees' Perspective.

Journal: Frontiers in cell and developmental biology
Published: March 07, 2022

Nintedanib and Dasatinib Treatments Induce Protective Autophagy as a Potential Resistance Mechanism in MPM Cells.

Nintedanib and Dasatinib Treatments Induce Protective Autophagy as a Potential Resistance Mechanism in MPM Cells.

Journal: Frontiers in cell and developmental biology
Published: January 11, 2022

Studying Autophagy In Vivo in the Mammary Gland and in Xenograft Samples.

Studying Autophagy In Vivo in the Mammary Gland and in Xenograft Samples.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: January 01, 2022

A Dual HiBiT-GFP-LC3 Lentiviral Reporter for Autophagy Flux Assessment.

A Dual HiBiT-GFP-LC3 Lentiviral Reporter for Autophagy Flux Assessment.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: January 01, 2022
Showing 1-12 of 24

Last Updated: 09/26/2026